IMVT
Immunovant, Inc.
Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer
Total Trades
139
Buys
6
Sells
132
Largest Trade
$1M+
Insiders
14
Institutional Funds
145
Inst. Value
$1M+
Activist Filings
13
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Butchko Julia G. | Chief Development … | SELL | $15K–$50K | 1K | $19.73 | Jul 13, 2023 |
| Macias William L. | Chief Medical Offi… | SELL | $1K–$15K | 509 | $16.29 | Apr 26, 2023 |
| Levine Mark S. | Chief Legal Officer | SELL | $15K–$50K | 3K | $16.29 | Apr 26, 2023 |
| Barnett Eva Renee | CFO | SELL | $50K–$100K | 3K | $15.27 | Apr 19, 2023 |
| Butchko Julia G. | Chief Development … | SELL | $15K–$50K | 2K | $15.27 | Apr 19, 2023 |
| Salzmann Peter | CEO | SELL | $50K–$100K | 3K | $15.27 | Apr 19, 2023 |
| Macias William L. | Chief Medical Offi… | SELL | $1K–$15K | 537 | $18.24 | Feb 3, 2023 |
| Levine Mark S. | Chief Legal Officer | SELL | $100K–$500K | 10K | $18.51 | Jan 27, 2023 |
| Salzmann Peter | CEO | SELL | $50K–$100K | 4K | $16.80 | Jan 13, 2023 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $1M+ | 60K | $16.79 | Jan 13, 2023 |
| Barnett Eva Renee | CFO | SELL | $50K–$100K | 5K | $16.75 | Jan 13, 2023 |
| Macias William L. | Chief Medical Offi… | SELL | $500K+ | 45K | $16.75 | Jan 13, 2023 |
| Macias William L. | Chief Medical Offi… | SELL | $1K–$15K | 341 | $9.67 | Oct 25, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $1K–$15K | 928 | $9.18 | Oct 17, 2022 |
| Salzmann Peter | CEO | SELL | $15K–$50K | 3K | $9.18 | Oct 17, 2022 |
| Barnett Eva Renee | CFO | SELL | $100K–$500K | 13K | $9.44 | Oct 13, 2022 |
| Roivant Sciences Ltd. | 10% Owner | BUY | $1M+ | 417K | $6.00 | Oct 7, 2022 |
| Pande Atul | Director | BUY | $50K–$100K | 15K | $5.60 | Oct 4, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $1K–$15K | 535 | $4.67 | Sep 29, 2022 |
| Salzmann Peter | CEO | SELL | $1K–$15K | 2K | $4.67 | Sep 29, 2022 |
| Torti Frank | Director | BUY | $100K–$500K | 20K | $5.81 | Sep 29, 2022 |
| Salzmann Peter | CEO | SELL | $1K–$15K | 2K | $5.83 | Sep 1, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $1K–$15K | 548 | $5.83 | Sep 1, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $1K–$15K | 510 | $4.27 | Jul 29, 2022 |
| Salzmann Peter | CEO | SELL | $1K–$15K | 2K | $4.27 | Jul 29, 2022 |
| Macias William L. | Chief Medical Offi… | SELL | $1K–$15K | 322 | $4.70 | Jul 26, 2022 |
| Salzmann Peter | CEO | SELL | $1K–$15K | 1K | $4.02 | Jul 1, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $1K–$15K | 460 | $4.02 | Jul 1, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $1K–$15K | 492 | $3.79 | May 25, 2022 |
| Salzmann Peter | CEO | SELL | $1K–$15K | 1K | $3.79 | May 25, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $1K–$15K | 541 | $4.72 | Apr 29, 2022 |
| Salzmann Peter | CEO | SELL | $1K–$15K | 2K | $4.72 | Apr 29, 2022 |
| Macias William L. | Chief Medical Offi… | SELL | $1K–$15K | 1K | $4.98 | Apr 20, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $15K–$50K | 6K | $5.90 | Apr 14, 2022 |
| Salzmann Peter | CEO | SELL | $100K–$500K | 19K | $5.90 | Apr 14, 2022 |
| Butchko Julia G. | Chief Dev. & Tech.… | SELL | $100K–$500K | 55K | $7.25 | Jan 11, 2022 |
| Barnett Eva Renee | CFO | SELL | $100K–$500K | 30K | $7.25 | Jan 11, 2022 |
| Salzmann Peter | CEO | SELL | $500K+ | 125K | $7.25 | Jan 11, 2022 |
| Macias William L. | Chief Medical Offi… | SELL | $100K–$500K | 27K | $8.28 | Jan 7, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 145 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Deep Track Capital, LP | 11.5M | $1M+ | SH |
| STATE STREET CORP | 3.8M | $1M+ | SH |
| Two Seas Capital LP | 2.9M | $1M+ | SH |
| Alpine Global Management, LLC | 2.6M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 2.5M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 2.5M | $1M+ | SH |
| Point72 Asset Management, L.P. | 2.0M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 2.0M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $1M+ | SH |
| Logos Global Management LP | 1.4M | $1M+ | SH |
| Aberdeen Group plc | 1.2M | $1M+ | SH |
| MORGAN STANLEY | 1.2M | $1M+ | SH |
| Soleus Capital Management, L.P. | 1.1M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 700K | $1M+ | SH |
| Candriam S.C.A. | 680K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 643K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 467K | $1M+ | SH |
| Pictet Asset Management Holding SA | 381K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 353K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 265K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Dec 12, 2025
55.9%
113.3M shares
SC 13G/A · Nov 5, 2025
8.4%
14.7M shares
SC 13D/A · Apr 21, 2025
56.9%
96.7M shares
SC 13G · Mar 26, 2025
5.6%
9.5M shares
SC 13G/A · Mar 7, 2025
10.1%
17.1M shares
SC 13D/A · Jan 15, 2025
56.9%
96.7M shares
SC 13G/A · Nov 12, 2024
8.6%
12.5M shares
SC 13G/A · Feb 14, 2024
0.7%
1.0M shares
SC 13D/A · Oct 4, 2023
55.3%
79.8M shares
SC 13G/A · Feb 14, 2023
7.5%
9.7M shares
SC 13G/A · Dec 5, 2022
0.0%
0 shares
SC 13G/A · Dec 2, 2022
5.9%
7.6M shares
SC 13G · Feb 11, 2022
5.8%
6.8M shares